Handa S、Lee J-O、Derkach A 等：接受维莫非尼单药治疗的复发或难治性毛细胞白血病患者的长期疗效。Blood.2022;140(25):2663-2671.

{"title":"Handa S、Lee J-O、Derkach A 等：接受维莫非尼单药治疗的复发或难治性毛细胞白血病患者的长期疗效。Blood.2022;140(25):2663-2671.","authors":"","doi":"10.1182/blood.2024026969","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"144 19","pages":"2068"},"PeriodicalIF":21.0000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Handa S, Lee J-O, Derkach A, et al. Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy. Blood. 2022;140(25):2663-2671.\",\"authors\":\"\",\"doi\":\"10.1182/blood.2024026969\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9102,\"journal\":{\"name\":\"Blood\",\"volume\":\"144 19\",\"pages\":\"2068\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1182/blood.2024026969\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood.2024026969","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}